Solid Biosciences Inc
NASDAQ:SLDB
Income Statement
Earnings Waterfall
Solid Biosciences Inc
Revenue
|
0
USD
|
Operating Expenses
|
-104.3m
USD
|
Operating Income
|
-104.3m
USD
|
Other Expenses
|
8.3m
USD
|
Net Income
|
-96m
USD
|
Income Statement
Solid Biosciences Inc
Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||
Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
3
N/A
|
7
+107%
|
10
+51%
|
14
+30%
|
12
-10%
|
15
+21%
|
11
-24%
|
8
-28%
|
6
-24%
|
0
N/A
|
0
N/A
|
0
N/A
|
|
Operating Income | ||||||||||||||||||||||||||||
Operating Expenses |
(35)
|
(48)
|
(55)
|
(57)
|
(63)
|
(68)
|
(76)
|
(90)
|
(99)
|
(109)
|
(119)
|
(114)
|
(106)
|
(97)
|
(86)
|
(82)
|
(85)
|
(85)
|
(86)
|
(93)
|
(101)
|
(100)
|
(103)
|
(112)
|
(109)
|
(111)
|
(104)
|
|
Selling, General & Administrative |
(10)
|
(13)
|
(15)
|
(14)
|
(15)
|
(16)
|
(18)
|
(21)
|
(21)
|
(24)
|
(25)
|
(23)
|
(23)
|
(21)
|
(22)
|
(22)
|
(24)
|
(26)
|
(27)
|
(28)
|
(29)
|
(29)
|
(24)
|
(29)
|
(29)
|
(29)
|
(28)
|
|
Research & Development |
(24)
|
(35)
|
(40)
|
(43)
|
(48)
|
(52)
|
(58)
|
(69)
|
(77)
|
(85)
|
(95)
|
(91)
|
(83)
|
(76)
|
(65)
|
(59)
|
(61)
|
(60)
|
(59)
|
(64)
|
(72)
|
(72)
|
(78)
|
(83)
|
(80)
|
(82)
|
(77)
|
|
Operating Income |
(35)
N/A
|
(48)
-39%
|
(55)
-13%
|
(57)
-3%
|
(63)
-11%
|
(68)
-9%
|
(76)
-11%
|
(90)
-19%
|
(99)
-10%
|
(109)
-11%
|
(119)
-9%
|
(114)
+5%
|
(106)
+7%
|
(97)
+8%
|
(86)
+11%
|
(78)
+9%
|
(78)
+0%
|
(75)
+4%
|
(72)
+4%
|
(81)
-12%
|
(86)
-6%
|
(89)
-4%
|
(94)
-6%
|
(106)
-12%
|
(109)
-3%
|
(111)
-2%
|
(104)
+6%
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||
Interest Income Expense |
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
1
|
1
|
0
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
3
|
4
|
6
|
8
|
7
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(2)
|
(2)
|
(2)
|
(2)
|
0
|
0
|
0
|
0
|
0
|
(2)
|
(2)
|
6
|
11
|
13
|
13
|
0
|
|
Total Other Income |
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
(0)
|
(0)
|
(0)
|
(1)
|
1
|
|
Pre-Tax Income |
(34)
N/A
|
(47)
-40%
|
(53)
-13%
|
(55)
-4%
|
(62)
-12%
|
(67)
-9%
|
(75)
-11%
|
(89)
-18%
|
(97)
-10%
|
(107)
-11%
|
(117)
-9%
|
(114)
+2%
|
(107)
+7%
|
(99)
+8%
|
(88)
+11%
|
(79)
+11%
|
(78)
+0%
|
(75)
+4%
|
(72)
+4%
|
(81)
-12%
|
(87)
-8%
|
(89)
-3%
|
(86)
+4%
|
(91)
-6%
|
(90)
+1%
|
(91)
-1%
|
(96)
-6%
|
|
Net Income | ||||||||||||||||||||||||||||
Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Income from Continuing Operations |
(34)
|
(47)
|
(53)
|
(55)
|
(62)
|
(67)
|
(75)
|
(89)
|
(97)
|
(107)
|
(117)
|
(114)
|
(107)
|
(99)
|
(88)
|
(79)
|
(78)
|
(75)
|
(72)
|
(81)
|
(87)
|
(89)
|
(86)
|
(91)
|
(90)
|
(91)
|
(96)
|
|
Income to Minority Interest |
2
|
2
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Net Income (Common) |
(16)
N/A
|
(29)
-85%
|
(39)
-33%
|
(55)
-40%
|
(62)
-12%
|
(67)
-9%
|
(75)
-11%
|
(89)
-18%
|
(97)
-10%
|
(107)
-11%
|
(117)
-9%
|
(114)
+2%
|
(107)
+7%
|
(99)
+8%
|
(88)
+11%
|
(79)
+11%
|
(78)
+0%
|
(75)
+4%
|
(72)
+4%
|
(81)
-12%
|
(87)
-8%
|
(89)
-3%
|
(86)
+4%
|
(91)
-6%
|
(90)
+1%
|
(91)
-1%
|
(96)
-6%
|
|
EPS (Diluted) |
-7.43
N/A
|
-13.72
-85%
|
-18.3
-33%
|
-23.28
-27%
|
-26.21
-13%
|
-29.29
-12%
|
-33.69
-15%
|
-38.14
-13%
|
-41.83
-10%
|
-36.99
+12%
|
-43.57
-18%
|
-35.73
+18%
|
-33.27
+7%
|
-30.68
+8%
|
-25.5
+17%
|
-13.19
+48%
|
-10.44
+21%
|
-10
+4%
|
-10.14
-1%
|
-10.74
-6%
|
-11.57
-8%
|
-11.88
-3%
|
-10.1
+15%
|
-4.63
+54%
|
-4.59
+1%
|
-4.52
+2%
|
-4.83
-7%
|